Hexagon Capital Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,981
Closed -$24.5K – 1297
2025
Q1
$24.5K Sell
2,981
-247
-8% -$2.07K ﹤0.01% 683
2024
Q4
$26.7K Buy
3,228
+1,844
+133% +$14.8K ﹤0.01% 684
2024
Q3
$10.6K Sell
1,384
-1,017
-42% -$9.37K ﹤0.01% 904
2024
Q2
$24.9K Buy
2,401
+1,307
+119% +$14.3K 0.01% 621
2024
Q1
$13.1K Buy
1,094
+737
+206% +$8.19K ﹤0.01% 786
2023
Q4
$3.86K Buy
357
+327
+1,090% +$3.98K ﹤0.01% 1017
2023
Q3
$415 Sell
30
-7
-19% -$102 ﹤0.01% 1288
2023
Q2
$443 Sell
37
-49
-57% -$553 ﹤0.01% 1280
2023
Q1
$1.01K Sell
86
-83
-49% -$1.21K ﹤0.01% 1181
2022
Q4
$2.85K Buy
169
+110
+186% +$1.81K ﹤0.01% 1020
2022
Q3
$1K Hold
59
– – ﹤0.01% 1241
2022
Q2
$1K Buy
+59
New +$991 ﹤0.01% 1109

Other funds holding PTEN

Hexagon Capital Partners's PTEN Position: Q2 2025 in Review

Hexagon Capital Partners sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 2,981 shares — an estimated $24.5K sold.

Hexagon Capital Partners first reported a position in PTEN in Q2 2022 and held it in 12 quarters. The position peaked at $26.7K in Q4 2024. 360 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.

  • Hexagon Capital Partners reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 2,981 Patterson-UTI shares in Q2 2025, an estimated $24.5K.
  • Hexagon Capital Partners first reported a position in Patterson-UTI in Q2 2022 and held it in 12 quarters.
  • Hexagon Capital Partners's Patterson-UTI position peaked at $26.7K in Q4 2024.
  • 360 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.